DAVID SKILLIN: Open Payments
NPI 1699504480 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 56 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $425 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $469 |
| PFIZER INC. | 7 | $222 |
| AstraZeneca Pharmaceuticals LP | 6 | $220 |
| Lilly USA, LLC | 1 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $32 |
Products named: VRAYLAR, BREZTRI, COMIRNATY, AIRSUPRA, UBRELVY, REXULTI, PREVNAR 20, Veozah.
Industry payments across CA — which companies pay providers there.
